Skip to main content

Table 1 Demographic data of early-onset VAP (n = 42) and late-onset VAP (n = 148)

From: Microorganisms and clinical outcomes of early- and late-onset ventilator-associated pneumonia at Srinagarind Hospital, a tertiary center in Northeastern Thailand

Characteristics

Early-onset VAP

n (%)

Late-onset VAP

n (%)

Mean age in years (SD)

58.5 (16.9)

65.9 (15.7)

Male

34 (81)

93 (62.8)

Ward

  

 Medical ICU

14 (33.3)

82 (55.4)

 Surgical ICU

21 (50.0)

52 (35.1)

 General medicine ward

3 (7.1)

8 (5.4)

 General surgery ward

4 (9.5)

6 (4.1)

Underlying diseases

28 (66.7)

120 (81.1)

 Hypertension

17 (40.5)

62 (41.9)

 Diabetes mellitus

10 (23.8)

42 (28.4)

 Cardiovascular disease

11 (26.2)

40 (27.0)

 Renal failure

4 (9.5)

37(25.0)

 Neurological disease

6 (14.3)

22 (14.9)

 Dyslipidemia

4 (9.5)

17 (11.5)

 Lung disease

6 (14.3)

13 (8.8)

 Gastrointestinal disease

2 (4.8)

11(7.4)

 Other

1 (2.4)

17 (11.5)

Hospitalized within 90 days

4 (9.5)

10 (6.8)

Antibiotic therapy in the prior month

22 (52.4)

101 (68.2)

Mean SAP II score (SD)

40.9 (14.1)

44.4 (12.9)

Chest radiographic finding

  

 Lobar pneumonia

34 (80.9)

111 (75.0)

 Multilobar pneumonia

8 (19.0)

37 (25.0)

 Pleural effusion

12 (28.6)

42 (28.4)

  1. VAP ventilator-associated pneumonia, SD standard deviation, ICU intensive care unit, IQR interquartile range, SAP II score simplified acute physiology II score